Skip to main content
. 2021 Sep 7;8:654867. doi: 10.3389/fmed.2021.654867

Figure 3.

Figure 3

GB1a alleviates the symptoms of DSS-induced UC in mice. (A–D) GB1a treatment ameliorated DSS-induced body weight loss (A), DAI scores raising (B), colon shortening (C,D). (E,F) GB1a attenuates colonic pathological damage in UC mice (E) and decreased the histological scores of the colon tissues (F). (G) GB1a intervention significantly reduced the serum MPO activity in UC mice. Data are presented as means ± SD (n = 7/group). *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the DSS-incubated group.